353
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency

, &
Pages 233-242 | Received 25 Jun 2017, Accepted 17 Sep 2017, Published online: 17 Oct 2017

References

  • Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18:113–120.
  • Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011;63:427–440.
  • Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharmaceut. 2013;453:142–156.
  • Tian XN, Li H, Zhang DR, et al. Parenteral nanosuspension of a novel synthesized antitumor candidate: investigation of tissue biodistributions and plasma pharmacokinetics. Colloid Surface A. 2013;436:868–872.
  • Salazar J, Müller RH, Möschwitzer JP. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets. Eur J Pharm Sci. 2013;49:565–577.
  • Yue PF, Li Y, Wan J, et al. Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property. Int J Pharmaceut. 2013;454:269–277.
  • Liu T, Muller RH, Moschwitzer JP. Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension. Expert Opin Drug Deliv. 2015;12:1741–1754.
  • George M, Ghosh I. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci. 2013;48:142–152.
  • Knieke C, Sommer M, Peukert W. Identifying the apparent and true grinding limit. Powder Technol. 2009;195:25–30.
  • Torrado G, Fraile S, Torrado S, et al. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods. Int J Pharmaceut. 1998;166:55–63.
  • Maged A, Mahmoud AA, Ghorab MM. Nano spray drying technique as a novel approach to formulate stable econazole nitrate nanosuspension formulations for ocular use. Mol Pharmaceut. 2016;13:2951–2965.
  • Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interface Sci. 2015;223:40–54.
  • Möschwitzer J, Müller RH. New method for the effective production of ultrafine drug nanocrystals. J Nanosci Nanotechnol. 2006;6:3145–3153.
  • Liu T, Müller RH, Möschwitzer JP. Systematical investigation of a combinative particle size reduction technology for production of resveratrol nanosuspensions. AAPS PharmSciTech 2017;18:1683–1691.
  • Lestari ML, Muller RH, Moschwitzer JP. Systematic screening of different surface modifiers for the production of physically stable nanosuspensions. J Pharm Sci. 2015;104:1128–1140.
  • Yuminoki K, Tachibana S, Nishimura Y, et al. Scaling up nano-milling of poorly water soluble compounds using a rotation/revolution pulverizer. Die Pharmazie. 2016;72:56–64.
  • Lintingre E, Lequeux F, Talini L, et al. Control of particle morphology in the spray drying of colloidal suspensions. Soft Matter. 2016;12:7435–7444.
  • Sloth J. Surface composition and morphology of particles dried individually and by spray drying. Drying Technol. 2015;33:757–767.
  • Elversson J, Millqvist-Fureby A. Aqueous two-phase systems as a formulation concept for spray-dried protein. Int J Pharmaceut. 2005;294:73–87.
  • Hilden LR, Morris KR. Physics of amorphous solids. J Pharm Sci. 2004;93:3–12.
  • Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86:1–12.
  • Popova M, Szegedi A, Mavrodinova V, et al. Preparation of resveratrol-loaded nanoporous silica materials with different structures. J Solid State Chem. 2014;219:37–42.
  • Vyaznikova MY, Nikolaeva SS, Smirnova LP, et al. Study of the state of water in a rutin standard. Pharm Chem J. 1997;31:34–36.
  • Giron D, Goldbronn C, Mutz M, et al. Solid state characterizations of pharmaceutical hydrates. J Therm Anal Calorim. 2002;68:453–465.
  • Salazar J, Ghanem A, Muller RH, et al. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. Eur J Pharm Biopharm. 2012;81:82–90.
  • Wojnarowska Z, Grzybowska K, Adrjanowicz K, et al. Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material. Mol Pharm. 2010;7:1692–1707.
  • Baird JA, Santiago-Quinonez D, Rinaldi C, et al. Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state. Pharm Res. 2012;29:271–284.
  • Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm. 2013;453:253–284.
  • Singh SK, Makadia V, Sharma S, et al. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration. Drug Deliv Transl Res. 2017;7:395–407.
  • Mauludin R. Preparation and storage stability of rutin nanosuspensions. J Pharm Investig. 2013;43:395–404.
  • Lai F, Franceschini I, Corrias F, et al. Maltodextrin fast dissolving films for quercetin nanocrystal delivery. a feasibility study. Carbohydr Polym. 2015;121:217–223.
  • Van Eerdenbrugh B, Raina S, Hsieh YL, et al. Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments. Pharm Res. 2014;31:969–982.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.